LTC4

Ltc4 is a lipid of Fatty Acyls (FA) class. Ltc4 is associated with abnormalities such as Asthma, Eosinophilia, Pulmonary Eosinophilia, Pneumonia and Cardiovascular Diseases. The involved functions are known as Signal, Gene Expression, Stimulus, Signal Transduction and Metabolic Inhibition. Ltc4 often locates in Plasma membrane, Cytoplasm, Back, Cytoplasmic and Tissue membrane. The associated genes with LTC4 are STIM1 gene, ABCC2 gene, CD9 gene, Mutant Proteins and Amino Acids, Aromatic. The related lipids are glycolithocholate.

Cross Reference

Introduction

To understand associated biological information of LTC4, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with LTC4?

LTC4 is suspected in Pneumonia, Asthma, Pulmonary Eosinophilia, Eosinophilia, Cardiovascular Diseases, Disintegration and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with LTC4

MeSH term MeSH ID Detail
Airway Obstruction D000402 13 associated lipids
Stomach Ulcer D013276 75 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Burns D002056 34 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Arthritis D001168 41 associated lipids
Hypotension D007022 41 associated lipids
Gastritis D005756 27 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Osteosarcoma D012516 50 associated lipids
Carcinoma, Small Cell D018288 21 associated lipids
Asthma D001249 52 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Ulcer D014456 16 associated lipids
Metabolism, Inborn Errors D008661 46 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Peritonitis D010538 38 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Leukemia D007938 74 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Leukemia, Myelogenous, Chronic, BCR-ABL Positive D015464 17 associated lipids
Myocardial Ischemia D017202 11 associated lipids
Glomerulonephritis D005921 35 associated lipids
Brain Diseases, Metabolic, Inborn D020739 10 associated lipids
Hyperbilirubinemia D006932 11 associated lipids
Brain Ischemia D002545 89 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Nasal Polyps D009298 26 associated lipids
Ear Diseases D004427 7 associated lipids
Respiratory Hypersensitivity D012130 18 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Anaphylaxis D000707 35 associated lipids
Pneumococcal Infections D011008 7 associated lipids
Eosinophilia D004802 4 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Cough D003371 19 associated lipids
Dermatitis, Atopic D003876 19 associated lipids
Status Asthmaticus D013224 4 associated lipids
Pseudoxanthoma Elasticum D011561 2 associated lipids
Rhinitis, Allergic, Perennial D012221 6 associated lipids
Acute-Phase Reaction D000210 12 associated lipids
Uveitis D014605 14 associated lipids
Periapical Periodontitis D010485 6 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Angina Pectoris D000787 27 associated lipids
Hyperbilirubinemia, Hereditary D006933 3 associated lipids
Rhinitis, Allergic, Seasonal D006255 7 associated lipids
Drug Eruptions D003875 30 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Mesenteric Vascular Occlusion D008641 4 associated lipids
Atherosclerosis D050197 85 associated lipids
Leukemia-Lymphoma, Adult T-Cell D015459 25 associated lipids
Pulmonary Disease, Chronic Obstructive D029424 16 associated lipids
Asthma, Exercise-Induced D001250 10 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Wounds, Nonpenetrating D014949 4 associated lipids
Cholestasis, Extrahepatic D001651 7 associated lipids
Insect Bites and Stings D007299 4 associated lipids
Carotid Artery Injuries D020212 8 associated lipids
Respiratory Syncytial Virus Infections D018357 10 associated lipids
Common Bile Duct Diseases D003137 3 associated lipids
Cestode Infections D002590 3 associated lipids
Neointima D058426 3 associated lipids
Asbestosis D001195 8 associated lipids
Phlebitis D010689 1 associated lipids
Picornaviridae Infections D010850 4 associated lipids
Eosinophilic Esophagitis D057765 3 associated lipids
Per page 10 20 50 100 | Total 75

PubChem Associated disorders and diseases

What pathways are associated with LTC4

Lipid pathways are not clear in current pathway databases. We organized associated pathways with LTC4 through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with LTC4?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with LTC4?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with LTC4?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with LTC4?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with LTC4?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with LTC4

Download all related citations
Per page 10 20 50 100 | Total 1173
Authors Title Published Journal PubMed Link
Sanchez Mejia RO et al. Matrix-associated transforming growth factor-beta1 primes mouse bone marrow-derived mast cells for increased high-affinity Fc receptor for immunoglobulin E-dependent eicosanoid biosynthesis. 2000 Am. J. Respir. Cell Mol. Biol. pmid:10783127
Macfarlane AJ et al. Sputum cysteinyl leukotrienes increase 24 hours after allergen inhalation in atopic asthmatics. 2000 Am. J. Respir. Crit. Care Med. pmid:10806153
Sakamoto H et al. Involvement of phospholipid hydroperoxide glutathione peroxidase in the modulation of prostaglandin D2 synthesis. 2000 J. Biol. Chem. pmid:11010961
Nishio T et al. Molecular identification of a rat novel organic anion transporter moat1, which transports prostaglandin D(2), leukotriene C(4), and taurocholate. 2000 Biochem. Biophys. Res. Commun. pmid:10973807
Karimi K et al. Stem cell factor and interleukin-4 increase responsiveness of mast cells to substance P. 2000 Exp. Hematol. pmid:10880748
Kivity S et al. Eosinophil influx into the airways in patients with exercise-induced asthma. 2000 Respir Med pmid:11192956
Hamasaki Y et al. (9-[4-acetyl-3-hydroxy-2-n-propylphenoxy) methyl]-3-(1H-tetrazol-5-yl)-4H-pyrido [1,2-a] pyrimidin-4-one), AS-35, inhibits leukotriene synthesis. 2000 Int. J. Immunopharmacol. pmid:10785545
Bandeira-Melo C et al. Cyclooxygenase-2-derived prostaglandin E2 and lipoxin A4 accelerate resolution of allergic edema in Angiostrongylus costaricensis-infected rats: relationship with concurrent eosinophilia. 2000 J. Immunol. pmid:10623853
Yakubu MA and Leffler CW Enhanced pial arteriolar sensitivity to bioactive agents following exposure to endothelin-1. 2000 Life Sci. pmid:10665982
Mitsunobu F et al. Enhanced peripheral leukocyte leukotriene production and bronchial hyperresponsiveness in asthmatics. 2000 Eur. Respir. J. pmid:11028668
Arakida Y et al. Effect of combined leukotriene D(4) and thromboxane A(2) receptor antagonist on mediator-controlled resistance in guinea pigs. 2000 Eur. J. Pharmacol. pmid:10969159
Ohbayashi H and Yamaki KI Both inhalant and intravenous uroguanylin inhibit leukotriene C4-induced airway changes. 2000 Peptides pmid:11068092
Thorén S and Jakobsson PJ Coordinate up- and down-regulation of glutathione-dependent prostaglandin E synthase and cyclooxygenase-2 in A549 cells. Inhibition by NS-398 and leukotriene C4. 2000 Eur. J. Biochem. pmid:11029586
Moore BB et al. GM-CSF regulates bleomycin-induced pulmonary fibrosis via a prostaglandin-dependent mechanism. 2000 J. Immunol. pmid:11034414
Robbiani DF et al. The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes. 2000 Cell pmid:11114332
Okumura H et al. Reversal of P-glycoprotein and multidrug-resistance protein-mediated drug resistance in KB cells by 5-O-benzoylated taxinine K. 2000 Mol. Pharmacol. pmid:11093797
Morlion BJ et al. Cysteinyl-leukotriene generation as a biomarker for survival in the critically ill. 2000 Crit. Care Med. pmid:11098969
Anderson MR and Blumer JL Prognostic markers in sepsis: the role of leukotrienes. 2000 Crit. Care Med. pmid:11098993
Malaviya R et al. Treatment of allergic asthma by targeting janus kinase 3-dependent leukotriene synthesis in mast cells with 4-(3', 5'-dibromo-4'-hydroxyphenyl)amino-6,7-dimethoxyquinazoline (WHI-P97). 2000 J. Pharmacol. Exp. Ther. pmid:11082424
Capper EA et al. Modulation of human monocyte activities by tranilast, SB 252218, a compound demonstrating efficacy in restenosis. 2000 J. Pharmacol. Exp. Ther. pmid:11082441
Díaz AM et al. In vitro anti-inflammatory activity of iridoids and triterpenoid compounds isolated from Phillyrea latifolia L. 2000 Biol. Pharm. Bull. pmid:11085357
Nothacker HP et al. Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: discovery of a subtype selective agonist. 2000 Mol. Pharmacol. pmid:11093801
Bäck M et al. Antagonist resistant contractions of the porcine pulmonary artery by cysteinyl-leukotrienes. 2000 Eur. J. Pharmacol. pmid:10936497
Tran HS et al. The cardiovascular hemodynamics and leukotriene kinetics during prostacyclin and anti-prostacyclin antibody infusions in septic shock. 2000 Shock pmid:10847636
Heise CE et al. Characterization of the human cysteinyl leukotriene 2 receptor. 2000 J. Biol. Chem. pmid:10851239
Malaviya R and Abraham SN Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis. 2000 J. Leukoc. Biol. pmid:10857857
Mayatepek E et al. Defects in the synthesis of cysteinyl leukotrienes: a new group of inborn errors of metabolism. 2000 J. Inherit. Metab. Dis. pmid:10896305
Okamoto M et al. Effects of perilla seed oil supplementation on leukotriene generation by leucocytes in patients with asthma associated with lipometabolism. 2000 Int. Arch. Allergy Immunol. pmid:10878492
Douglas IS et al. CD4+ T cell and eosinophil adhesion is mediated by specific ICAM-3 ligation and results in eosinophil activation. 2000 J. Immunol. pmid:10706734
Skaltsa H et al. Inhibition of prostaglandin E2 and leukotriene C4 in mouse peritoneal macrophages and thromboxane B2 production in human platelets by flavonoids from Stachys chrysantha and Stachys candida. 2000 Biol. Pharm. Bull. pmid:10706410
Aiso M et al. Biliary excretion of bile acids and organic anions in zone 1- and zone 3-injured rats. 2000 Liver pmid:10726959
Gutmann H et al. P-glycoprotein- and mrp2-mediated octreotide transport in renal proximal tubule. 2000 Br. J. Pharmacol. pmid:10694230
Sundkvist E et al. Leukotriene C(4) (LTC(4)) does not share a cellular efflux mechanism with cGMP: characterisation of cGMP transport by uptake to inside-out vesicles from human erythrocytes. 2000 Biochim. Biophys. Acta pmid:10631301
Annila I et al. Bee venom induces high histamine or high leukotriene C4 release in skin of sensitized beekeepers. 2000 Jul-Aug J Investig Allergol Clin Immunol pmid:11039839
Kamohara M et al. Functional characterization of cysteinyl leukotriene CysLT(2) receptor on human coronary artery smooth muscle cells. 2001 Biochem. Biophys. Res. Commun. pmid:11587533
Wehner J and Neuber K Staphylococcus aureus enterotoxins induce histamine and leukotriene release in patients with atopic eczema. 2001 Br. J. Dermatol. pmid:11531797
Sano A et al. Regulation of eosinophil function by phosphatidylinositol-specific PLC and cytosolic PLA(2). 2001 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:11557588
Qian YM et al. Characterization of binding of leukotriene C4 by human multidrug resistance protein 1: evidence of differential interactions with NH2- and COOH-proximal halves of the protein. 2001 J. Biol. Chem. pmid:11507101
Strenzke N et al. Mercuric chloride enhances immunoglobulin E-dependent mediator release from human basophils. 2001 Toxicol. Appl. Pharmacol. pmid:11485386
Miura K et al. Differences in functional consequences and signal transduction induced by IL-3, IL-5, and nerve growth factor in human basophils. 2001 J. Immunol. pmid:11490016
Falcón-Pérez JM et al. Domain interactions in the yeast ATP binding cassette transporter Ycf1p: intragenic suppressor analysis of mutations in the nucleotide binding domains. 2001 J. Bacteriol. pmid:11466279
Bölke E et al. Changes of gut barrier function during anesthesia and cardiac surgery. 2001 Angiology pmid:11515987
Abad MJ et al. Effects of furocoumarins from Cachrys trifida on some macrophage functions. 2001 J. Pharm. Pharmacol. pmid:11518028
Ito K et al. Mutation of Trp1254 in the multispecific organic anion transporter, multidrug resistance protein 2 (MRP2) (ABCC2), alters substrate specificity and results in loss of methotrexate transport activity. 2001 J. Biol. Chem. pmid:11500505
Tornhamre S et al. Inhibitory effects of helenalin and related compounds on 5-lipoxygenase and leukotriene C(4) synthase in human blood cells. 2001 Biochem. Pharmacol. pmid:11543725
Miura K et al. Localizing a control region in the pathway to leukotriene C(4) secretion following stimulation of human basophils with anti-IgE antibody. 2001 J. Immunol. pmid:11739523
Wang J et al. [The effects of resuscitation with hypertonic saline solution on the postburn pulmonary injury in scalded dogs]. 2001 Zhonghua Shao Shang Za Zhi pmid:11774813
Eppihimer MJ and Schaub RG Soluble P-selectin antagonist mediates rolling velocity and adhesion of leukocytes in acutely inflamed venules. 2001 Microcirculation pmid:11296849
Díaz Lanza AM et al. Lignan and phenylpropanoid glycosides from Phillyrea latifolia and their in vitro anti-inflammatory activity. 2001 Planta Med. pmid:11345691
Sjöström M et al. Human umbilical vein endothelial cells generate leukotriene C4 via microsomal glutathione S-transferase type 2 and express the CysLT(1) receptor. 2001 Eur. J. Biochem. pmid:11322876
Bandeira-Melo C et al. Extranuclear lipid bodies, elicited by CCR3-mediated signaling pathways, are the sites of chemokine-enhanced leukotriene C4 production in eosinophils and basophils. 2001 J. Biol. Chem. pmid:11274187
Zhang DW et al. Identification of an amino acid residue in multidrug resistance protein 1 critical for conferring resistance to anthracyclines. 2001 J. Biol. Chem. pmid:11278596
Ito K et al. Mutation of a single conserved tryptophan in multidrug resistance protein 1 (MRP1/ABCC1) results in loss of drug resistance and selective loss of organic anion transport. 2001 J. Biol. Chem. pmid:11278867
Leslie EM et al. Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and atpase activities by interaction with dietary flavonoids. 2001 Mol. Pharmacol. pmid:11306701
Schroeder JT et al. Human basophils: mediator release and cytokine production. 2001 Adv. Immunol. pmid:11293121
Zhang DW et al. Identification of a nonconserved amino acid residue in multidrug resistance protein 1 important for determining substrate specificity: evidence for functional interaction between transmembrane helices 14 and 17. 2001 J. Biol. Chem. pmid:11429411
Hevko JM and Murphy RC Electrospray ionization and tandem mass spectrometry of cysteinyl eicosanoids: leukotriene C4 and FOG7. 2001 J. Am. Soc. Mass Spectrom. pmid:11444597
Cai J et al. Functional expression of multidrug resistance protein 1 in Pichia pastoris. 2001 Biochemistry pmid:11444977
Zaitsu M et al. A novel pharmacologic action of glucocorticosteroids on leukotriene C4 catabolism. 2001 J. Allergy Clin. Immunol. pmid:11447392
Ieiri S et al. The mechanism for the contraction induced by leukotriene C4 in guinea-pig taenia coli. 2001 Br. J. Pharmacol. pmid:11399670
Zhu X et al. Role of mitogen-activated protein kinase-mediated cytosolic phospholipase A2 activation in arachidonic acid metabolism in human eosinophils. 2001 J. Immunol. pmid:11418683
Gurish MF and Austen KF The diverse roles of mast cells. 2001 J. Exp. Med. pmid:11435478
de las Heras B et al. Effects of six diterpenes on macrophage eicosanoid biosynthesis. 2001 Life Sci. pmid:12005260
Leslie EM et al. Transport of the beta -O-glucuronide conjugate of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by the multidrug resistance protein 1 (MRP1). Requirement for glutathione or a non-sulfur-containing analog. 2001 J. Biol. Chem. pmid:11375986
Muccitelli RM et al. Cysteinyl leukotriene receptor assays. 2001 Curr Protoc Pharmacol pmid:22293965
Downey P et al. Renal concentrating defect in mice lacking group IV cytosolic phospholipase A(2). 2001 Am. J. Physiol. Renal Physiol. pmid:11249852
Vicente AM et al. Modulation of haem oxygenase-1 expression by nitric oxide and leukotrienes in zymosan-activated macrophages. 2001 Br. J. Pharmacol. pmid:11454666
Martin V et al. Molecular cloning and functional characterization of murine cysteinyl-leukotriene 1 (CysLT(1)) receptors. 2001 Biochem. Pharmacol. pmid:11705452
Aoki M et al. Studies on mechanisms of low emetogenicity of YM976, a novel phosphodiesterase type 4 inhibitor. 2001 J. Pharmacol. Exp. Ther. pmid:11504812
Bäck M et al. An alternative pathway for metabolism of leukotriene D(4): effects on contractions to cysteinyl-leukotrienes in the guinea-pig trachea. 2001 Br. J. Pharmacol. pmid:11487525
Fukuishi N et al. Antiallergic effect of ardisiaquinone A, a potent 5-lipoxygenase inhibitor. 2001 Phytomedicine pmid:11824521
Oliveira SH et al. SCF-induced airway hyperreactivity is dependent on leukotriene production. 2001 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:11350804
Qian YM et al. Glutathione stimulates sulfated estrogen transport by multidrug resistance protein 1. 2001 J. Biol. Chem. pmid:11102445
Murakami M et al. Distinct arachidonate-releasing functions of mammalian secreted phospholipase A2s in human embryonic kidney 293 and rat mastocytoma RBL-2H3 cells through heparan sulfate shuttling and external plasma membrane mechanisms. 2001 J. Biol. Chem. pmid:11106649
Okayama Y et al. A comparison of mediators released or generated by IFN-gamma-treated human mast cells following aggregation of Fc gamma RI or Fc epsilon RI. 2001 J. Immunol. pmid:11254731
Tohda Y et al. Role of chemical mediators in airway hyperresponsiveness in an asthmatic model. 2001 Respiration pmid:11223734
Setoguchi H et al. Leukotriene C(4) enhances the contraction of porcine tracheal smooth muscle through the activation of Y-27632, a rho kinase inhibitor, sensitive pathway. 2001 Br. J. Pharmacol. pmid:11156567
Amann R et al. Effects of COX-1 and COX-2 inhibitors on eicosanoid biosynthesis and the release of substance P from the guinea-pig isolated perfused lung. 2001 Inflamm. Res. pmid:11235022
Gronert K et al. Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses. 2001 Am. J. Pathol. pmid:11141472
Picado C and Valero A COX-1 sparing drugs in aspirin-sensitive asthma. 2001 Clin. Exp. Allergy pmid:11251618
Terlouw SA et al. Role of multidrug resistance protein 2 (MRP2) in glutathione-bimane efflux from Caco-2 and rat renal proximal tubule cells. 2001 Br. J. Pharmacol. pmid:11682439
Schroeder JT et al. Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine. 2001 Clin. Exp. Allergy pmid:11591186
Hui Y et al. The murine cysteinyl leukotriene 2 (CysLT2) receptor. cDNA and genomic cloning, alternative splicing, and in vitro characterization. 2001 J. Biol. Chem. pmid:11591709
Duffy SM et al. Resting and activation-dependent ion channels in human mast cells. 2001 J. Immunol. pmid:11591748
Ohno N et al. Prognostic significance of multidrug resistance protein in adult T-cell leukemia. 2001 Clin. Cancer Res. pmid:11595704
Miura K et al. Piceatannol is an effective inhibitor of IgE-mediated secretion from human basophils but is neither selective for this receptor nor acts on syk kinase at concentrations where mediator release inhibition occurs. 2001 Clin. Exp. Allergy pmid:11696049
Bölke E et al. Inflammatory response during abdominal and thyroid surgery: a prospective clinical trial on mediator release. 2001 Shock pmid:11699069
Fernández MA et al. New insights into the mechanism of action of the anti-inflammatory triterpene lupeol. 2001 J. Pharm. Pharmacol. pmid:11732756
Thomas LL et al. Peptide-based analysis of amino acid sequences important to the biological activity of eosinophil granule major basic protein. 2001 Immunol. Lett. pmid:11578692
Abeywardena MY et al. Dietary n-3 and n-6 polyunsaturated oils and airway contractility. 2001 Apr-May Prostaglandins Leukot. Essent. Fatty Acids pmid:11418024
Karaman O et al. The comparison of the efficacy of fluticasone propionate with cetirizine in perennial allergic rhinitis. 2001 Mar-Apr Allergol Immunopathol (Madr) pmid:11420028
King BO et al. Tirofiban administration attenuates platelet and platelet-neutrophil conjugation but not neutrophil degranulation during in vitro VAD circulation. 2001 May-Jun ASAIO J. pmid:11374774
Malaviya R and Uckun FM Leflunomide metabolite analogue alpha-cyano-beta-hydroxy-beta-methyl-N-[3-(trifluoromethyl)phenyl]propenamide inhibits IgE/FcepsilonRI receptor-mediated mast cell leukotriene release and allergic asthma in mice. 2001 Sep-Oct Am J Ther pmid:11550070
Gongadze NV and Kezeli TD Use of zafirlucast, cysteine-containing leukotriene antagonist, in epinephrine-induced heart injury. 2002 Bull. Exp. Biol. Med. pmid:12802449
Koike K et al. Multiple membrane-associated tryptophan residues contribute to the transport activity and substrate specificity of the human multidrug resistance protein, MRP1. 2002 J. Biol. Chem. pmid:12388549
Yang Y et al. Structural and functional consequences of mutating cysteine residues in the amino terminus of human multidrug resistance-associated protein 1. 2002 J. Biol. Chem. pmid:12235150
Bandeira-Melo C et al. Intracrine cysteinyl leukotriene receptor-mediated signaling of eosinophil vesicular transport-mediated interleukin-4 secretion. 2002 J. Exp. Med. pmid:12235216
Tabas LB and Dantzig AH A high-throughput assay for measurement of multidrug resistance protein-mediated transport of leukotriene C4 into membrane vesicles. 2002 Anal. Biochem. pmid:12413474
Belinsky MG et al. Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6). 2002 Cancer Res. pmid:12414644
Mastalerz L et al. Clinical and genetic features underlying the response of patients with bronchial asthma to treatment with a leukotriene receptor antagonist. 2002 Eur. J. Clin. Invest. pmid:12534456